Oculis Holding AG (OCS) Return on Assets (2023 - 2026)

Oculis Holding AG's (OCS) quarterly Return on Assets came in at 0.69% in Q1 2026, up 59.0% year-on-year from 0.44% in Q1 2025, and up 16.77% quarter-over-quarter from 0.83% in Q4 2025.

Oculis Holding AG (OCS) Return on Assets (2023 - 2026) Analysis & Trends

Oculis Holding AG's Return on Assets history runs 4 years deep, the most recent figure standing at 0.69% for Q1 2026.

  • On a quarterly basis, Return on Assets rose 59.0% year-over-year to 0.69% in Q1 2026; TTM through Mar 2026 was 0.69%, a 59.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
  • Return on Assets climbed to 0.69% in Q1 2026 per OCS's latest filing, from 0.83% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q1 2024 and bottomed at 1.65% in Q4 2024.
  • The 4-year median for Return on Assets is 0.83% (2025), against an average of 0.73%.
  • Across the five-year window, Return on Assets slumped 165 bps in 2024 and soared 82 bps in 2025, its largest moves.
  • Year by year, Return on Assets stood at 0.01% in 2023, then slumped by 23198 bps to 1.65% in 2024, then soared by 50 bps to 0.83% in 2025, then climbed by 17 bps to 0.69% in 2026.
  • Per Business Quant, the three latest OCS Return on Assets figures stand at 0.69% (Q1 2026), 0.83% (Q4 2025), and 0.99% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -0.69%
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -0.01%
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.00%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.00%
7 Belite Bio 61.40 Bn 61.40 Bn - -0.80%
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 0.00%
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.69%
Dec 31, 2025 -0.83%
Sep 30, 2025 -0.99%
Jun 30, 2025 -1.05%
Mar 31, 2025 -1.28%
Dec 31, 2024 -1.65%
Sep 30, 2024 -1.56%
Jun 30, 2024 -0.01%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.01%
Sep 30, 2023 -0.01%